Previous business/academic article Next business/academic article
Business Articles Awards > General Antitrust

The importance of the new Competition innovation in life sciences

Ingrid Vandenborre, Competition Law Insight, 14 February 2017

See Ingrid Vandenborre's resume

Click here to read the full article online

Increasingly, EU merger control enforcement seems to be focused on the impact a proposed transaction is likely to have on innovation. This is reflected both in the EU Commission’s substantive review of recent transactions, as well as its proposed legislative change to increase the EU Commission’s jurisdiction over proposed transactions involving highly valued target companies with limited sales revenues. Both are particularly relevant to the pharmaceutical sector.

Download our brochure